Overview

Rabeprazole in Subjects With Gastroesophageal Reflux Disease (GERD)

Status:
Completed
Trial end date:
2007-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the production of mucin in GERD/RE subjects before and after 8 weeks of treatment with rabeprazole.
Phase:
Phase 2
Details
Lead Sponsor:
University of Kansas
Collaborators:
Eisai Inc.
PriCara, Unit of Ortho-McNeil, Inc.
Treatments:
Rabeprazole